Linearized colorimetric assay for cremophor EL: Application to pharmacokinetics after 1-hour paclitaxel infusions

Analytical Biochemistry

Volumn 261, Issue 2, 1998, Pages 198-202

  Brouwer, Eric ^a   Verweij, Jaap ^a   Hauns, Bernhard ^b   Loos, Walter J ^a   Nooter, Kees ^a   Mross, Klaus ^b   Stoter, Gerrit ^a   Sparreboom, Alex ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METADATA; PATIENT MONITORING; SURFACE ACTIVE AGENTS;

CANCER PATIENTS; COLORIMETRIC ASSAYS; COMPLEX FORMATIONS; COOMASSIE BRILLIANT BLUE G-250; DYE CONCENTRATION; LINEAR RELATIONSHIPS; PEAK WAVELENGTH; QUANTITATIVE DETERMINATIONS;

PATIENT TREATMENT;

ANAZOLENE SODIUM; CREMOPHOR; PACLITAXEL;

ACCURACY; ANALYTIC METHOD; ARTICLE; CANCER; CLINICAL ARTICLE; COLORIMETRY; COMPLEX FORMATION; DRUG DETERMINATION; DRUG FORMULATION; DRUG INFUSION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NONLINEAR SYSTEM; PRIORITY JOURNAL;

EID: 0032144286     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1006/abio.1998.2746     Document Type: Article

References (21)

1. Verweij J., Clavel M., Chevalier B. Ann. Oncol. 5:1994;495-506.
2. Kingston D. G. I. Trends Biotechnol. 12:1994;222-227.
3. Mathew A. E., Mejillano M. R., Nath J. P., Himes R. H., Stella V. J. J. Med. Chem. 35:1992;145-151.
4. Sparreboom A., Van Tellingen O., Nooijen W. J., Beijnen J. H. AntiCancer Drugs. 9:1998;1-17.
5. Adams J. D., Flora K. P., Goldspiel B. R., Wilson J. W., Finley R. J. Natl. Cancer Inst. 15:1993;189-194.
6. Weiss R. B., Donehower R. C., Wiernik P. H., Ohnuma T., Gralla R. J., Trump D. L., Baker J. R., Van Echo D. A., Von Hoff D. D., Leyland-Jones B. J. Clin. Oncol. 8:1990;1232-1239.
7. Dorr R. T. Ann. Pharmacother. 28:1994;S11-S14.
8. Waugh W. N., Trissel L. A., Stella V. J. Am. J. Hosp. Pharm. 48:1991;1520-1524.
9. Goldspiel, B. R. 1995, in, Paclitaxel in Cancer Treatment, 175, 186, Dekker, New York.
10. Sparreboom A., Loos W. J., Verweij J., De Vos A. I., Van der Burg M. E. L., Stoter G., Nooter K. Anal. Biochem. 255:1998;171-175.
11. Sparreboom A., Van Tellingen O., Huizing M. T., Nooijen W. J., Beijnen J. H. J. Chromatogr. 674:1996;261-268.
12. Webster L., Linsenmeyer M., Millward M., Morton C., Bishop J., Woodcock D. J. Natl. Cancer Inst. 85:1993;1685-1690.
13. Bradford M. M. Anal. Biochem. 72:1976;248-254.
14. Chial H. J., Thompson H. B., Splittgerber A. G. Anal. Biochem. 209:1993;258-266.
15. Zor T., Selinger Z. Anal. Biochem. 236:1996;302-308.
16. Shah V. P., Midha K. K., Dighe S., McGilveray I. J., Skelly J. P., Yacobi A., Layloff T., Viswanathan C. T., Cook C. E., McDowall R. D., Pittman K. A., Spector S. J. Pharm. Sci. 81:1992;309-312.
17. Loos W. J., Verweij J., Nooter K., Stoter G., Sparreboom A. J. Chromatogr. Biomed. Appl. 693:1997;437-441.
18. Mross K., Hauns B., Häring B., Bauknecht T., Meerpohl H. G., Unger C., Maier-Lenz H. Ann. Oncol. 9:1998;569-572.
19. Sparreboom A., Van Tellingen O., Nooijen W. J., Beijnen J. H. Cancer Res. 56:1996;2112-2115.
20. De Vos A. I., Nooter K., Verweij J., Loos W. J., Brouwer E., De Bruijn P., Ruijgrok E. J., Van der Burg M. E. L., Stoter G., Sparreboom A. Ann. Oncol. 8:1997;1145-1150.
21. Sparreboom A., Verweij J., Van der Burg M. E. L., Loos W. J., Brouwer E., Vigano L., Locatelli A., De Vos A. I., Nooter K., Stoter G., Gianni L. Clin. Cancer Res. 4:1998.